Durect Corp. Stock
Durect Corp. Stock
For the coming years our community has positive and negative things to say abot the Durect Corp. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Durect Corp. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Durect Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Durect Corp. | - | - | - | - | - | - | - |
| Ardelyx Inc. | 8.590% | 26.964% | 32.366% | 34.396% | 35.546% | 146.456% | 23.939% |
| Evolus Inc | 0.000% | -15.439% | -18.992% | -49.792% | -11.560% | -36.993% | 32.856% |
| Champions Oncology Inc | - | 0.901% | 10.891% | 17.647% | -3.448% | 43.590% | -36.364% |
Comments
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for DRRX provided by MarketBeat
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for DRRX provided by MarketBeat
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for DRRX provided by MarketBeat